Brian Myung Chang, MD | |
270 S Candy Ln, Cottonwood, AZ 86326-4164 | |
(480) 892-8400 | |
(480) 892-9533 |
Full Name | Brian Myung Chang |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 27 Years |
Location | 270 S Candy Ln, Cottonwood, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700879343 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 34356 (Arizona) | Secondary |
207WX0009X | Ophthalmology - Glaucoma Specialist | 34356 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Barnet Dulaney Perkins Eye Center, Pc | 0749288298 | 95 |
Southwestern Eye Center, Ltd | 1850296989 | 98 |
News Archive
With growing concerns among parents and policymakers about the rise in childhood obesity - heightened by the recent CDC report showing that obesity rose 37% between 1998 and 2006 - approximately two-thirds of middle and high school physical education teachers say that health-related fitness is the primary focus of their programs, according to a new survey conducted by the National Association for Sport and Physical Education (NASPE) and Polar.
What has previously been known as good cholesterol-high density lipoprotein (HDL)-has now been shown to be not so good in protecting women against atherosclerosis while they are transitioning through menopause. That's according to a new study from the University of Pittsburgh Graduate School of Public Health that was presented last week at the annual meeting of The North American Menopause Society in Las Vegas.
Eat your vegetables is a well-worn message that weary parents have been giving reluctant children at the dinner table for generations.
The Employer and Broker Solutions Group of A.D.A.M., Inc., which provides client acquisition, retention, and agency management solutions to nearly 600 of the nation's top health benefits brokers, today announced that it has launched Advisor Tools 2.0, A.D.A.M.'s comprehensive suite of applications for brokers that includes proprietary benchmark reporting, research and regulatory information, and other valuable HR tools.
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg.
› Verified 4 days ago
Entity Name | Southwestern Eye Center, Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023063187 PECOS PAC ID: 1850296989 Enrollment ID: O20031203000181 |
News Archive
With growing concerns among parents and policymakers about the rise in childhood obesity - heightened by the recent CDC report showing that obesity rose 37% between 1998 and 2006 - approximately two-thirds of middle and high school physical education teachers say that health-related fitness is the primary focus of their programs, according to a new survey conducted by the National Association for Sport and Physical Education (NASPE) and Polar.
What has previously been known as good cholesterol-high density lipoprotein (HDL)-has now been shown to be not so good in protecting women against atherosclerosis while they are transitioning through menopause. That's according to a new study from the University of Pittsburgh Graduate School of Public Health that was presented last week at the annual meeting of The North American Menopause Society in Las Vegas.
Eat your vegetables is a well-worn message that weary parents have been giving reluctant children at the dinner table for generations.
The Employer and Broker Solutions Group of A.D.A.M., Inc., which provides client acquisition, retention, and agency management solutions to nearly 600 of the nation's top health benefits brokers, today announced that it has launched Advisor Tools 2.0, A.D.A.M.'s comprehensive suite of applications for brokers that includes proprietary benchmark reporting, research and regulatory information, and other valuable HR tools.
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg.
› Verified 4 days ago
Entity Name | Barnet Dulaney Perkins Eye Center, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376574707 PECOS PAC ID: 0749288298 Enrollment ID: O20061117000349 |
News Archive
With growing concerns among parents and policymakers about the rise in childhood obesity - heightened by the recent CDC report showing that obesity rose 37% between 1998 and 2006 - approximately two-thirds of middle and high school physical education teachers say that health-related fitness is the primary focus of their programs, according to a new survey conducted by the National Association for Sport and Physical Education (NASPE) and Polar.
What has previously been known as good cholesterol-high density lipoprotein (HDL)-has now been shown to be not so good in protecting women against atherosclerosis while they are transitioning through menopause. That's according to a new study from the University of Pittsburgh Graduate School of Public Health that was presented last week at the annual meeting of The North American Menopause Society in Las Vegas.
Eat your vegetables is a well-worn message that weary parents have been giving reluctant children at the dinner table for generations.
The Employer and Broker Solutions Group of A.D.A.M., Inc., which provides client acquisition, retention, and agency management solutions to nearly 600 of the nation's top health benefits brokers, today announced that it has launched Advisor Tools 2.0, A.D.A.M.'s comprehensive suite of applications for brokers that includes proprietary benchmark reporting, research and regulatory information, and other valuable HR tools.
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Brian Myung Chang, MD 4800 N 22nd St, Phoenix, AZ 85016-4701 Ph: (480) 892-8400 | Brian Myung Chang, MD 270 S Candy Ln, Cottonwood, AZ 86326-4164 Ph: (480) 892-8400 |
News Archive
With growing concerns among parents and policymakers about the rise in childhood obesity - heightened by the recent CDC report showing that obesity rose 37% between 1998 and 2006 - approximately two-thirds of middle and high school physical education teachers say that health-related fitness is the primary focus of their programs, according to a new survey conducted by the National Association for Sport and Physical Education (NASPE) and Polar.
What has previously been known as good cholesterol-high density lipoprotein (HDL)-has now been shown to be not so good in protecting women against atherosclerosis while they are transitioning through menopause. That's according to a new study from the University of Pittsburgh Graduate School of Public Health that was presented last week at the annual meeting of The North American Menopause Society in Las Vegas.
Eat your vegetables is a well-worn message that weary parents have been giving reluctant children at the dinner table for generations.
The Employer and Broker Solutions Group of A.D.A.M., Inc., which provides client acquisition, retention, and agency management solutions to nearly 600 of the nation's top health benefits brokers, today announced that it has launched Advisor Tools 2.0, A.D.A.M.'s comprehensive suite of applications for brokers that includes proprietary benchmark reporting, research and regulatory information, and other valuable HR tools.
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg.
› Verified 4 days ago
Dr. David S Deutch, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 294 W State Route 89a, Suite 114, Cottonwood, AZ 86326 Phone: 928-649-7935 Fax: 928-649-7936 | |
Farshid Paydar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 401 S Calvary Way Ste D, Cottonwood, AZ 86326 Phone: 928-649-2600 Fax: 928-649-7847 |